A perfusion-capable microfluidic bioreactor for assessing microbial heterologous protein production by Lee, Kevin S. et al.
A perfusion-capable microfluidic bioreactor for assessing 
microbial heterologous protein production
Nicholas J. Mozdzierza,b, Kerry R. Loveb,c, Kevin S. Leed, Harry L. T. Leed, Kartik A. Shahb, 
Rajeev J. Rame, and J. Christopher Lovea,b
aDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 
02139, USA
bThe David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of 
Technology, Cambridge, MA 02139, USA
cMIT Center for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, MA 
02139, USA
dPharyx, Inc., Woburn, MA 01801, USA
eResearch Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, MA, 
02139, USA
Abstract
We present an integrated microfluidic bioreactor for fully continuous perfusion cultivation of 
suspended microbial cell cultures. This system allowed continuous and stable heterologous protein 
expression by sustaining the cultivation of Pichia pastoris over 11 days. This technical capability 
also allowed testing the impact of perfusion conditions on protein expression. This advance should 
enable small-scale models for process optimization in continuous biomanufacturing.
Methods for the continuous cultivation of cells have the potential to improve the efficiency 
of processes for manufacturing biopharmaceuticals. One mode is cultivation by perfusion: 
fresh media flows continuously through a bioreactor while biomass remains in the 
bioreactor. Perfusion offers advantages over traditional batch-style manufacturing, enabling 
consistent production of proteins over time and reduced cultivation volumes. Development 
of robust processes using perfusion, however, requires a rigorous understanding of key 
experimental parameters influencing overall productivity.
Approaches that use quality-by-design (QbD) for process development often employ scaled-
down systems for cultivation to gain experimental understanding and build rigorous models 
of the process. Scale-down models for batch and fed-batch modalities are widely employed 
in the biopharmaceutical industry. Many technologies exist that enable a range of 
operational modalities, volumes, and strategies for control. Shake flasks, nonetheless, remain 
a primary model for complex modes of cultivation: these experiments may use baffled glass 
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vessels with volumes greater than 1 L or microtiter plates adapted for automated high-
throughput studies. The simplicity of shake flasks makes them accessible, but they are a 
poor model for the conditions present in a bioreactor. It is difficult to monitor critical 
parameters and no control is possible. In contrast, multiplexed bench-scale mimics of large 
stirred tank vessels incorporate many features and controls typically employed in 
commercial bioreactors, including dynamic gassing, biomass monitoring, and closed-loop 
control of temperature, pH, and dissolved oxygen. Both reusable glass-based (e.g. Sartorius 
Biostat Q6+) and disposable polymer-based (e.g. Eppendorf DASbox) vessels provide 
working volumes less than 1 L., Some platforms allow many (12 - 24) reactors to test 
multiple conditions in parallel (e.g. Sartorious ambr250). None of the currently available 
bench-top bioreactors, however, are capable of routine cultivation by perfusion without 
extensive retrofitting.
Single-use microfluidic devices hold substantial promise as screening tools to optimize 
conditions for cellular cultivation and manufacturing processes. To date, microfluidic 
systems have been developed to mimic the monitoring and control capabilities of full-scale 
bioreactors for batch culture.- Recently, a polydimethylsiloxane-polycarbonate (PDMS-PC) 
device with a 1 mL working volume and an online analytics suite capable of monitoring and 
controlling temperature, pH, dissolved oxygen (DO), and cell density for chemostat and 
turbidostat continuous culture was demonstrated. No microfluidic bioreactors capable of 
supporting dense suspensions of cells by continuous perfusion have been reported to date. 
Here, we present a microbioreactor system that supports continuous perfusion and show that 
this system: (i) supports robust microbial growth; (ii) provides a well-regulated environment 
for cultivation and expression of therapeutically-relevant heterologous proteins; and (iii) 
serves as a platform technology for testing conditions for cultivation by perfusion that 
promote improved protein expression.
The perfusion-capable microscale bioreactor chip (“perfusostat”) comprises a spin-coated 80 
μm PDMS membrane chemically bonded to flanking layers of CNC machined PC with 
integrated valve architecture and analytics as described previously (Fig. 1). Briefly, three 
interconnected growth chambers create a combined effective working volume of 1.0 mL. 
Four automatically refillable 40 μL on-chip reservoirs sourced by pressurized media bottles 
supply fresh media to the growth chambers. Periodic pressure-driven deflections of the 
PDMS membrane facilitate homogeneous mixing of the culture. Dissolved oxygen control 
was achieved by regulating the concentration of oxygen in the gas mixture used to drive 
mixing, thereby promoting diffusion of oxygen through the PDMS membrane. Perfusion 
was achieved by collecting sterile culture fluid passed through a 1 cm diameter 0.2 μm 
polyethersulfone (PES) membrane integrated into one of the three growth chambers. A 
separate outlet channel permitted unfiltered sampling of the growth chamber contents for 
offline analysis.
Cultivations in the perfusion-capable device were monitored and controlled using a 
combination of on- and offline sensors as previously described using an integrated 
microbioreactor control module. “Fluorescence lifetime” measurements of DO and pH were 
acquired using sensor patches embedded in the growth chamber (Fig. 1)., Optical density 
was assessed at 630 nm using an LED and a photodiode detector integrated into the 
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hardware module on opposing sides of the bioreactor chip. Online temperature was 
measured using an integrated circuit temperature sensor.
Both mammalian and microbial cells are used commercially to make biologic drugs. 
Escherichia coli and Saccharomyces cerevisiae are common microbial hosts for producing 
biopharmaceuticals, but the methylotrophic yeast Pichia pastoris is an alternative platform 
used to manufacture two FDA-approved therapeutic proteins., Moreover, P. pastoris 
represents a promising alternative to traditional mammalian hosts owing to its genetic 
stability, capacity for cultivation at high densities, and capability to produce fully-humanized 
post-translational modifications.- Given its industrial relevance and our own experience with 
this host, we elected to use Pichia pastoris to demonstrate the capabilities of the perfusostat 
device.
Perfusostat fermentations were performed with strains of Pichia pastoris (NRRL 11430) 
modified to express either recombinant human growth hormone (rhGH) or recombinant 
interferon alfa-2b (rIFNα-2b) under the control of the alcohol oxidase-1 (AOX1) promoter.
Working cell banks (WCBs) of these strains were prepared as described in the ESI. Except 
where otherwise noted, fermentations were performed using a three-phase fermentation 
protocol. Briefly, WCB aliquots were thawed, re-suspended in buffered glycerol-complex 
medium (BMGY; see ESI for protocol), and inoculated at a cell density of ∼0.1 OD as 
measured offline (600 nm, 1 cm pathlength). Cultures were then grown in BMGY (25 °C, 
20% air. sat., and 1.0 mL/h perfusion rate). Upon reaching a cell density of 0.75 OD as 
measured on-line (630 nm, 508 um pathlength), closed-loop feedback control was enabled 
and periodic metered ejections allowed maintenance of this optical density. Cultures 
continued under biomass control for ∼9 h (3 doubling times) to acclimate the cells to the 
cultivation environment and setpoints., Exchange of BMGY media for buffered methanol-
complex medium (BMMY; see ESI for protocol) was performed by filling and evacuating 
the growth chamber 30 times in 30 minutes. This exchange induced protein production, and 
cultures were then maintained at 25 °C, 20% air. sat., and a perfusion rate of 0.75 mL/h. pH 
was adjusted during cultivations by addition of fresh buffered media at pH 6.0. Mixing of 
growth chamber contents occurred at a membrane deflection frequency of 2 Hz. A schematic 
of this three-phase cultivation protocol is provided in the ESI (Fig. S1).
Cellular viability during cultivation is a common critical parameter in bioprocess 
development. We first confirmed that the bioreactor provided a suitable cultivation 
environment for Pichia pastoris when operated as a perfusostat. Duplicate cultivations of 
both drug-producing strains in the chips grew in an exponential fashion, as expected, and 
stabilized at a preset online OD630 of 0.75 under closed-loop biomass control (Figs. S2a,b). 
Minor variations in the cell densities at inoculation likely altered the time required to reach 
the stated optical density setpoint for each culture. The mean calculated specific growth rate 
(μ, h-1) across all four cultivations (Fig. 2) was 0.306 h-1 ± 0.006 h-1. These data agree well 
with reported values for μ in P. pastoris grown in shake flasks (0.17 h-1). They also suggest 
that our perfusostat bioreactor chip provides a growth environment comparable to a typical 
shake flask.
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We then confirmed that cultures of Pichia pastoris in the perfusostat chips displayed normal 
kinetics of protein expression. Working cell bank aliquots of the hGH-secreting strain were 
reconstituted directly in BMMY induction media at an offline cell density of ∼12 OD600. 
Replicate perfusostats were seeded with these suspensions and operated at a perfusion rate 
of 1.0 mL/h. Immediately following inoculation, both cultures experienced a brief (∼3 h) 
exponential growth phase (data not shown), likely due to the mixed carbon source (glycerol/
methanol) initially available in the system. Measurable levels of secreted hGH were detected 
from both cultures within 4-6 hours of inoculation (Fig. 3a). Furthermore, after initial 
detection of protein, both perfusostats continued to yield comparable and consistent rates of 
hGH accumulation for an additional 16 h (Fig. 3b). These results suggest that our perfusion-
capable bioreactors provide a suitable environment for protein expression and secretion by P. 
pastoris.
We then evaluated the ability of the perfusion-capable microfluidic bioreactors to screen 
conditions that promote enhanced protein expression. Given that induction of heterologous 
protein expression by methanol feeding is critical to developing conditions for fermentation 
with P. pastoris, we first screened a set of non-standard induction media. Specifically, we 
tested whether or not induction of protein production with methanol concentrations greater 
than 1% (v/v) could improve secreted titers of hGH. Four devices were inoculated with 
separate aliquots of the hGH working cell bank and outgrown in pre-mixed BMGY. In each 
device, a separate BMMY blend (i.e. 1%, 2%, 5%, or 10% methanol (v/v)) was mixed in 
real-time from concentrated stock solutions of individual media components. Cultivation 
under 2% methanol (v/v) conditions yielded an improvement in hGH expression rates over 
standard BMMY (1% methanol) within ∼48 h post-induction (Fig. 4a). Concentrations of 
methanol above 5% (v/v) negatively impacted protein expression, likely resulting from 
decreased culture viability due to prolonged exposure to methanol., Nonetheless, the rate of 
hGH accumulation under each separate methanol concentration tested remained essentially 
constant with time (Fig. 4b). These observed differences in stable secreted protein 
accumulation rates may indicate achievement of different conditionally dependent metabolic 
states by each culture tested.
In addition to media development, optimizing conditions for perfusion requires matching the 
cell density in the bioreactor with the perfusion rate through the bioreactor to ensure proper 
nutrient addition and metabolite removal. Maximum titers of secreted protein are typically 
achieved using a “push-to-low” strategy where the highest sustainable cell density at a given 
perfusion rate is determined. We applied the push-to-low methodology to hGH 
fermentations. Two perfusostat devices were inoculated and outgrown to a stable online 
OD630 of either 0.5 or 0.75 at a perfusion rate and mixing frequency of 1.0 mL/h and 2 Hz, 
respectively. Media was exchanged to induce the cultures and the perfusion rates were 
lowered stepwise from 1.0 to 0.25 mL/h at a mixing frequency of 4 Hz. Each perfusion rate 
was maintained for a period of approximately one day (∼8 doubling times) to enable 
acclimation of the cultures to the new cultivation conditions., Samples of perfused cell 
culture fluid were collected during the last 8 hours (∼3 doubling times) of each period and 
analyzed for protein titer by ELISA (see ESI). As expected, the titers increased as the 
perfusion rate decreased to 0.5 mL/h for both cell densities tested (Fig. 5). Furthermore, the 
magnitudes of the stepwise increases in titer were similar across both cell densities, 
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potentially indicating that the nutrient demands or metabolite production do not differ 
significantly with these densities. Titers of hGH measured at a perfusion rate of 0.25 mL/h 
did not trend as expected based on the measurements at other perfusion rates. We believe 
that this outcome likely resulted from inadequate mixing. Culture viscosities and cell 
viabilities were also non-optimal at this lowest perfusion rate.
Many of the benefits typically associated with perfusion—smaller equipment volumes, 
reduced operating expenses, and streamlined integration of unit operations—are predicated 
on the ability of these processes to sustain cultivations under stable conditions. As such, any 
system designed for perfusion cultivation must maintain key cultivation parameters and 
cellular productivity at constant levels for extended periods of time. To this end, we sought 
to demonstrate that the perfusostat devices could maintain a P. pastoris culture at stable 
levels of OD, DO, and protein secretion for an amount of time comparable to our previously 
reported non-perfusion bacterial growth studies (∼500 h). To test the long-term stability, we 
used duplicate fermentations of both hGH- and IFNα-2b-secreting strains (1% methanol 
(v/v) and 0.75 mL/h perfusion rate). Online OD630 and DO setpoints were stably maintained 
for ∼280 h post-induction (Fig. S3) with oscillatory deviations in DO of comparable 
amplitude to those commonly reported for small-scale Pichia fermentations., All four 
cultures achieved similar levels of protein secretion within 24 h of induction (Fig. 6a,b). 
Moreover, all four cultures continued secreting either hGH or IFNα-2b at stable levels 
through an additional 260 h of fermentation time.
 Conclusions
Here, we present a perfusion-capable microfluidic bioreactor that provides a suitable 
environment for sustained recombinant protein expression from a microbial host organism. 
To our knowledge, this is the first demonstration of heterologous protein production from a 
microbe cultivated under fully continuous perfusion conditions. Based on our testing of 
various media formulations and perfusion rates, we believe that our system can serve as a 
platform to screen for conditions that improve secreted protein titers. By implementing 
rigorous feedback control over key process parameters (e.g. OD, DO, perfusion rate), our 
devices maintained cultures of hGH- and IFNα-2b-expressing strains of P. pastoris in 
regimes of stable protein production for ∼11 days. This capability should enable scale-down 
studies to be run for the same periods of time as typical industrial processes (7 - 30 days). 
Traditional scale-down models such as shake flasks and microtiter plates do not offer 
consistent control for these lengths of time. Moreover, the ability of our system to provide a 
controlled environment over long time-scales, coupled with its small working volume (1 
mL) and simplicity of multiplexing, could enable high-throughput, parallelized studies of 
cell biology and genetics (e.g. genetic drift) under actual process conditions. Consequently, 
moving forward, we aim to demonstrate the comparability of our system to larger reactor 
systems, using both microbial and mammalian hosts, to fully enable its use in design-of-
experiment studies for industrial process development.
 Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Schematic representation of the perfusostat device
Fluid enters the growth chambers (blue) through four 40 uL reservoirs (purple) by the 
selective actuation of various valves (orange). Product-containing perfused media exits the 
device through a 0.2 um PES membrane (grey; labeled). Dissolved oxygen and pH 
measurements are acquired by patch-based sensors (pink and yellow) embedded within the 
top- and right-most growth chambers. Each chip incorporates two 508 μm path lengths (red) 
for OD630 sensing.
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Fig. 2. Determination of P. pastoris growth characteristics under perfusion conditions
hGH- and IFNα-2b-secreting strains of P. pastoris were inoculated in duplicate at an offline 
OD600 of ∼0.1 and grown under perfusostat conditions on non-inductive BMGY media. The 
“exponential regions” of all four growth profiles were log10 transformed and linear 
regressions were fit to the transformed data. For all growth curves, the “exponential region” 
was defined as the portion of the profile between t = 1 h and the initiation of closed-loop 
biomass control at online OD630 = 0.75.
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Fig. 3. Determination of the kinetics of heterologous protein expression by P. pastoris under 
perfusion
a) hGH production rate (μg/h) as a function of total cultivation time (h) for two parallel 
perfusostat fermentations of P. pastoris, as determined by capillary electrophoresis. Both 
cultures were inoculated directly in induction media (BMMY) at an offline OD600 of ∼12. 
Cultures were grown to a steady-state online OD630 of 0.75 and maintained at this cell 
density for the duration of the experiment. b) Offline OD600 normalized values of total hGH 
produced (μg) as calculated from the data presented in a) and plotted as a function of time 
post-induction (h). Error is represented as the range in technical duplicate capillary 
electrophoresis measurements.
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Figure 4. hGH expression by P. pastoris as a function of inducer (methanol) concentration
a) Offline OD600 normalized hGH production rate (μg/h) versus time post-induction (h) for 
each of four separate cultivations using induction media (BMMY) with distinct methanol 
concentrations, as determined by capillary electrophoresis. b) Offline OD600 normalized 
values of total hGH produced (μg) as calculated from the data presented in a) and plotted as 
a function of time post-induction (h). Error is represented as the range in technical duplicate 
capillary electrophoresis measurements.
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Fig. 5. hGH expression by P. pastoris as a function of cell density and perfusion rate
Offline OD600 normalized hGH titer (μg/mL), as determined by sandwich ELISA, and 
plotted as a multivariate function of perfusion rate (mL/h) and online OD630. Each of two 
perfusostats was set to maintain an online OD630 setpoint of either 0.5 or 0.75 and was 
stepped down through perfusion rates from 1.0 mL/h to 0.25 mL/h in 0.25 mL/h increments. 
Error bars represent 1σ.
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Fig. 6. Perfusostat cultivation sustained long-term culture productivity
a) Offline OD600 normalized hGH titer (μg/mL), determined by capillary electrophoresis, 
plotted as a function of time post-induction (h), and presented in biological duplicate. b) 
Offline OD600 normalized IFNα-2b titer (μg/mL), determined by capillary electrophoresis, 
plotted as a function of time post-induction (h), and presented in biological duplicate.
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